Coley Coleman
Kelsey Swingle (GrENG’25) has made a remarkable leap from doctoral training at Penn to a tenure-track faculty position at Rice University. Her pioneering work on lipid nanoparticle delivery of mRNA therapeutics targets critical women’s health issues like pre-eclampsia, addressing a major gap in reproductive medicine.
Trained in the Mitchell Lab and shaped by Penn’s Center for Precision Engineering for Health (CPE4H), Swingle pushes the boundaries of precision medicine with a focus on real-world impact. At Rice, she will launch her own lab exploring biomaterials, immune engineering and reproductive biology, continuing her mission to develop innovative therapies for under-treated conditions.
“Kelsey’s unique application is to use these technologies to treat specific diseases, such as to target the placenta during pregnancy,” says Daniel A. Hammer (GrEng’87), Alfred G. and Meta A. Ennis Professor of Bioengineering and Inaugural Director of the CPE4H. “Her work is a wonderful combination of precise molecular delivery applied to a real problem in human health.”
Read more about Swingle’s inspiring journey and groundbreaking science advancing health and personalized medicine on the Bioengineering blog.